n.szabo

TL2 · Gdańsk

Contributes reviews on supplier material. Based in Gdańsk.

Joined 24 March 2025 · last posted 5h

74 posts, newest first. Showing up to 150.

Sleep quality changes during weight loss Replied, post #32 · Wellbeing › Sleep · 28 Jul 2026 · 2 likes Adding thanks rather than a view. I do not have a view worth the space.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #129 · Evidence › Journal club · 25 Jul 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Reading it again,…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #54 · Pharmacology › Receptor biology · 24 Jul 2026 · 23 likes Where the receptor desensitisation reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Composite endpoints and the component doing the work Replied, post #7 · Evidence › Trials · 19 Jul 2026 · 0 likes Post #5 put the caveat in the right place and I want to underline it. Registration before enrolment, with the primary endpoint declared, is what makes outcome switching…
What to bring: records that a clinician can actually use — a second dataset Replied, post #32 · Clinical › Prescriber conversations · 13 Jul 2026 · 20 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #88 · Compounds › Repair & healing peptides · 10 Jul 2026 · 9 likes I had written a reply contradicting post #84 and deleted it. Here is what survived. Storage after reconstitution is where most of the practical questions land.…
Common supplements people ask about, assessed one at a time Replied, post #17 · Practice › Interactions · 7 Jul 2026 · 32 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
What to include when your question involves a chromatogram — one year on Replied, post #62 · Start Here › How to Ask · 4 Jul 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
[2026 update] Antibiotics and a course of something with delayed emptying Started this topic · Practice › Interactions · 29 Jun 2026 · 24 likes On the subject in the title: Antibiotics and a course of something with delayed emptying Working notes rather than a conclusion. Something changed and I would like to…
Alcohol: what is documented and what is folklore Replied, post #77 · Practice › Interactions · 26 Jun 2026 · 0 likes Checked the alcohol claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #24 · Evidence › Journal club · 23 Jun 2026 · 5 likes Worth separating semaglutide in MASH as a question about the compound from semaglutide in MASH as a question about the documentation. They get answered by different…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #58 · Practice › Administration · 20 Jun 2026 · 22 likes Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #63 · Compounds › Repair & healing peptides · 30 May 2026 · 10 likes Post #60 answers the question as asked. The question underneath it is different. I would keep Stability of BPC-157 and the decision it usually gets used for separate in…
A critique that turned out to be unfair, retracted by its author Replied, post #5 · Evidence › Study critique · 30 May 2026 · 12 likes That is a cleaner way of putting what I was circling around.
A supplier who responds to a discrepancy with silence — what changed since Replied, post #44 · Sourcing › Red flags · 10 May 2026 · 0 likes Post #41 is right about the mechanism and I think understates the practical bit. Documentation quality as a signal: a supplier that reports method identifiers,…
Does a peptide degrade silently, with no visual change? Replied, post #22 · Practice › Storage & stability · 6 May 2026 · 0 likes The failure mode on peptide is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #17 · Safety › Contraindications · 22 Apr 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #61 · Practice › Reconstitution · 21 Apr 2026 · 0 likes A 0.3 mL barrel has more space between graduations than a 1 mL barrel for the same volume, which is the entire practical argument for the smaller syringe. Resolution,…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #65 · Sourcing › Logistics · 30 Mar 2026 · 0 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. The short answer was in the first line; everything…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #30 · Sourcing › Independent verification · 7 Mar 2026 · 18 likes Janoshik would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #5 · Lounge › Introductions · 7 Mar 2026 · 0 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation. If it helps: the failure mode here is usually boring…
Contributing data without breaching anyone's privacy Replied, post #31 · Data & Tools › Datasets · 4 Mar 2026 · 0 likes Include the denominator. A collection of reports without knowing how many people did not report is uninterpretable in the direction everybody wants to interpret it.…
Measurement error in a self-reported exposure Replied, post #128 · Evidence › Study critique · 28 Feb 2026 · 2 likes Adding the measurement that post #127 says would settle it. I disagree with the framing of measurement error above, and I think it is a substantive disagreement rather…
Foaming during reconstitution and whether it matters — the long version Replied, post #41 · Practice › Reconstitution · 21 Feb 2026 · 14 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #96 · Compounds › Oral incretins · 5 Feb 2026 · 25 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Second pass at: What pooling buys you and what it destroys Replied, post #15 · Evidence › Meta-analyses · 4 Feb 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #28 · Clinical › Special populations · 22 Jan 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
Managing an unplanned gap in supply Replied, post #8 · Access › Shortages · 17 Jan 2026 · 0 likes Post #7 is right about the mechanism and I think understates the practical bit. Stockpiling in response to a shortage worsens it, which is true and is a poor argument…
A partial dose because the pen emptied mid-injection Replied, post #48 · Practice › Administration · 8 Jan 2026 · 17 likes Partial dose because the pen is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #16 · Data & Tools › Calculators · 5 Jan 2026 · 17 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
MHRA statements, read directly Replied, post #55 · Regional › UK & Ireland · 25 Dec 2025 · 19 likes Confirming post #53 from a second method, which matters more than confirming it from a second person. MHRA statements looks different depending on whether you are…
Aggregates and why a purity assay may miss them entirely Replied, post #26 · Analytics › Impurities & related substances · 24 Dec 2025 · 4 likes Picking up post #24: that is the part I would want checked first. My understanding of aggregates is a few years old and may have been superseded. If it has been, I…
Pen dose counters: what a click does and does not guarantee Replied, post #61 · Devices › Pens & autoinjectors · 16 Nov 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #153 · Practice › Reconstitution · 27 Oct 2025 · 7 likes 10 mg vial reconstituted three is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Realistic expectations for strength while losing weight quickly Replied, post #31 · Nutrition & Training › Resistance training · 26 Oct 2025 · 4 likes Everything in post #27 holds. The case it does not cover is the one I have. Anybody returning after a break should expect to start lower than they left, and expecting…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #86 · Practice › Reconstitution · 26 Oct 2025 · 24 likes That is clearer than the version I had in my head. Thank you.
Publishing an inconvenient result: a case study — the long version Replied, post #14 · Sourcing › Independent verification · 20 Oct 2025 · 3 likes Publishing an inconvenient result is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Payment mechanics and the recovery options that do not exist Replied, post #7 · Sourcing › Payments · 18 Oct 2025 · 9 likes I keep a log for payment mechanics specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #18 · Compounds › Semaglutide · 23 Sep 2025 · 4 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
A request that was declined, and the reasoning — a second dataset Replied, post #58 · Documentation › Wiki requests · 11 Aug 2025 · 23 likes If a request is declined, the reasoning is written down, and it is worth reading because it usually describes a better version of the same idea. I would want the raw…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #79 · Compounds › Retatrutide · 14 Jul 2025 · 0 likes Post #75 put the caveat in the right place and I want to underline it. Worth separating Triple agonism as a question about the compound from Triple agonism as a…
Interim analyses and stopping rules — does this still hold? Replied, post #29 · Evidence › Trials · 3 Jul 2025 · 1 like This follows post #26 rather than contradicting it. Trying to state the Interim analyses and stopping rules position in a way that someone who disagrees would recognise…
[2026 update] An appeal that failed, and what I would do differently Replied, post #27 · Access › Insurance & coverage · 8 Jun 2025 · 2 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
Coming back to: Getting a referral rather than a refusal Replied, post #40 · Clinical › Prescriber conversations · 7 Jun 2025 · 0 likes Adding the measurement that post #39 says would settle it. Nothing here is medical advice, and this subcategory exists to help people ask better questions rather than…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #81 · Practice › Reconstitution · 31 May 2025 · 18 likes Bookmarking this. I will come back when I have something worth adding.
Regional warehouse stock versus direct despatch Started this topic · Sourcing › Logistics · 10 May 2025 · 6 likes Posting this under the heading it deserves: Regional warehouse stock versus direct despatch Everything below is what sits behind that. Asking about regional warehouse…
Sequence verification for an obscure compound: how it is done Replied, post #29 · Compounds › Other compounds · 7 May 2025 · 12 likes Answering the question post #25 raises rather than the one it answers. Reporting rather than recommending, on sequence verification. What happened is above. Whether it…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #98 · Practice › Reconstitution · 6 May 2025 · 18 likes Post #95 is right about the mechanism and I think understates the practical bit. Worked example, since the arithmetic is the whole question. Five milligrams into one…
Cost per milligram, computed honestly across formats — the long version Replied, post #64 · Access › Pricing · 13 Apr 2025 · 7 likes The cost of an independent submission is worth stating in these threads, because it is the main reason people do not do it. The strength of my opinion here exceeds the…
Retatrutide dose escalation in the published trials Replied, post #120 · Compounds › Retatrutide · 12 Apr 2025 · 0 likes Post #119 describes the usual case. This is about the unusual one. Whether triple agonism is additive or synergistic is an open question and the published work does not…
Coverage for the indication versus for the drug Replied, post #24 · Access › Insurance & coverage · 9 Apr 2025 · 2 likes Post #23 answers the question as asked. The question underneath it is different. Coverage for the device and for the compound can be decided separately, which surprises…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #81 · Sourcing › Regulatory · 3 Mar 2025 · 0 likes I think the pharmaceutical compounding rules question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #62 · Sourcing › Regulatory · 2 Mar 2025 · 23 likes Post #59 is right about the mechanism and I think understates the practical bit. Marking my uncertainty on pharmaceutical compounding rules explicitly. I am confident…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #10 · Sourcing › Regulatory · 27 Feb 2025 · 5 likes Seconded. It reads as careful rather than confident, which is the right register.
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #15 · Sourcing › Independent verification · 23 Feb 2025 · 21 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. I looked this up rather than remembered it, which…
Coming back to: Official shortage notices and what they authorise Replied, post #30 · Access › Shortages · 20 Feb 2025 · 5 likes The arithmetic in post #27 is right; the assumption feeding it is the part to check. Regional differences during a shortage are large, and a supply position in one…
Why mass spectrometry cannot tell you about an epimer Replied, post #58 · Analytics › Mass spectrometry · 15 Feb 2025 · 19 likes Deamidation adds approximately one dalton and produces a species that frequently elutes very close to the parent. It is the hardest common impurity to see…
Review: a draft on reconstitution arithmetic, with objections Replied, post #5 · Documentation › Doc review · 28 Jan 2025 · 5 likes No notes. Posting so the count is not one.
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #16 · Evidence › Meta-analyses · 8 Jan 2025 · 1 like Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative…
What we do not know about retatrutide, listed explicitly Replied, post #42 · Compounds › Retatrutide · 3 Jan 2025 · 9 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #116 · Compounds › Oral incretins · 28 Dec 2024 · 33 likes Picking up post #115: that is the part I would want checked first. What I can speak to on Oral semaglutide bioavailability is narrow, so I will keep it narrow rather…
Oxidation pathways for methionine and tryptophan Replied, post #15 · Analytics › Impurities & related substances · 26 Dec 2024 · 1 like Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
Injection-site reactions: describing them precisely enough to be useful Replied, post #80 · Practice › Side effects · 17 Dec 2024 · 25 likes Helpful, and easy to find again, which is half of what a good reply is.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #62 · Compounds › Semaglutide · 5 Dec 2024 · 29 likes Post #60 and I disagree about the size of the effect, not about the direction. Injection site does not appear to matter much for semaglutide exposure. The published…
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #12 · Compounds › Repair & healing peptides · 4 Dec 2024 · 0 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #58 · Compounds › Tirzepatide · 27 Nov 2024 · 0 likes On storage: published stability data covers the licensed formulation at its licensed concentration. A research preparation reconstituted at home in a different diluent…
What we do not know about retatrutide, listed explicitly Replied, post #2 · Compounds › Retatrutide · 21 Nov 2024 · 0 likes Taking the opening post at face value and following it one step further. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class.…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #32 · Access › Insurance & coverage · 18 Nov 2024 · 11 likes Post #30 put the caveat in the right place and I want to underline it. Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and…
SURMOUNT-4 and what withdrawal data does and does not tell an individual Started this topic · Compounds › Tirzepatide · 8 Nov 2024 · 0 likes SURMOUNT-4 and what withdrawal data does and does not tell an individual — setting out what I have, and where I think it stops being reliable. I would like to disagree…
Anxiety in the first weeks: drug, situation, or both Replied, post #4 · Wellbeing › Mental health · 28 Sep 2024 · 2 likes The most useful reply I ever got about anxiety was a request to state my units. It sounds like pedantry and it has saved me twice.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #49 · Evidence › Journal club · 20 Sep 2024 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
A rising related-substance total over six months: degradation or method drift? Replied, post #19 · Analytics › Impurities & related substances · 30 Aug 2024 · 5 likes Coming back to post #15, because the follow-up matters more than the original answer. Truncation products: fragments from incomplete synthesis or from degradation. They…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 15 Jul 2024 · 10 likes The opening post is right about the mechanism and I think understates the practical bit. Where there is a genuine question, a measurement answers it and a supplement…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #3 · Practice › Side effects · 12 Jul 2024 · 4 likes The opening post is the version of this I will quote in future. One addition. Source for the nausea timeline figure, since it was asked for. It is in the discussion…